Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improved AD/ADRD Assessment Sensitivities Using a Novel In-Situ Sensor System

NCT04871698 is registered in ClinicalTrials.gov with National Institute on Aging (NIA) as lead sponsor.

NCT NCT04871698
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04871698 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improved AD/ADRD Assessment Sensitivities Using a Novel In-Situ Sensor System
Lead sponsor
National Institute on Aging (NIA)
Phase
Observational
Overall status
Unknown status
Start date
September 14, 2020
Completion date
March 31, 2022
Enrollment
140 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dementia, dementia alzheimers